Aprogen Medicines Inc. (KRX:007460)

Market Cap	221.79B
Revenue (ttm)	147.85B
Net Income (ttm)	-42.27B
Shares Out	291.07M
EPS (ttm)	-170.24
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,614,006
Average Volume	3,037,808
Open	748.00
Previous Close	748.00
Day's Range	744.00 - 822.00
52-Week Range	701.00 - 1,894.00
Beta	0.86
RSI	47.02
Earnings Date	Mar 20, 2025

About Aprogen Medicines

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foam...

• Industry: Conglomerates
• Sector: Industrials
• Founded: 1971
• Employees: 245
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 007460

Financial Performance

In 2023, Aprogen Medicines's revenue was 150.58 billion, an increase of 92.19% compared to the previous year's 78.35 billion. Losses were -55.62 billion, -43.62% less than in 2022.